medigraphic.com
ISSN 2307-2113 (Digital)
Revista Cubana de Información en Ciencias de la Salud (ACIMED)

2013, Número 4

<< Anterior Siguiente >>

Revista Cubana de Información en Ciencias de la Salud (ACIMED) 2013; 24 (4)


Frentes de investigación sobre vitiligo, un enfoque bibliométrico basado en Scopus

Vega ARL, Arencibia JR

Idioma: Ingles.
Referencias bibliográficas: 76
Paginas: 402-415
Archivo PDF: 309.32 Kb.


RESUMEN

La bibliometría se usa frecuentemente para analizar la evolución estructural de campos de investigación, especialmente en áreas biomédicas. El presente trabajo ofrece una macroestructura de la investigación científica sobre vitiligo durante los últimos 50 años a partir de métodos bibliométricos. Los datos fueron recuperados de Scopus. Un total de 6 109 artículos relacionados con el vitiligo fueron procesados. Fueron analizados los términos especializados basados en la estructura del tesauro Medical Subject Headings (MeSH) de la Biblioteca Nacional de Medicina de los Estados Unidos. Se desarrolló un enfoque estructural a partir del análisis de la co-ocurrencia de términos. Se utilizó el análisis de agrupamientos jerárquicos para identificar la macroestructura, a partir de la aplicación del algoritmo CONCOR (CONvergencia de CORrelaciones iteradas). La producción científica mundial sobre vitiligo mostró un crecimiento exponencial durante los últimos 50 años. El análisis estructural reveló ocho áreas de investigación divididas en dos bloques temáticos. En primer lugar, un bloque experimental que agrupa los estudios sobre el vitiligo, sus relaciones con el cáncer y otras enfermedades autoinmunes, su patofisiología y su patogénesis; y en segundo lugar, un bloque de estudios clínicos que agrupa diferentes enfoques terapéuticos, así como la incidencia y prevalencia de la enfermedad. La metodología aplicada ofrece una herramienta válida para la descripción y clasificación de dominios del conocimiento biomédicos. Además, permite obtener una macroestructura que puede ser validada a partir de revisiones bibliográficas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cavaller V. Datametrics? About the architecture of the metric disciplines. In: H. Kretschmer& F. Havemann (Eds.): Proceedings of WIS 2008, Fourth International Conference on Webometrics, Informetrics and Scientometrics & Ninth COLLNET Meeting. Berlin: Humboldt-Universitätzu Berlin, Institute for Library and Information Science (IBI); 2008.

  2. Borner K, Chen CM, Boyack KW. Visualizing knowledge domains. Annu Rev Inform Sci Technol. 2003;37:179-255.

  3. Glenisson P, Glanzel W, Janssens F, De Moor B. Combining full text and bibliometric information in mapping scientific disciplines. Inf Process Manage. 2005;41:1548-72.

  4. Morris SA, Van der Veer Martens B. Mapping research specialties. Annual Review of Information Science and Technology. 2008;42:213-95.

  5. Arencibia Jorge R, Vega Almeida RL, Marti Lahera Y. Domain analysis for the construction of a conceptual structure: A case study. Libres [Internet]. 2007 [cited 20 July 2013]. Available from: http://libres.curtin.edu.au/libres17n2/Arencibia-Jorge_Domain_Analysis.pdf/

  6. Chiu WT, Ho YS. Bibliometric analysis of homeopathy research during the period of 1991 to 2003. Scientometrics. 2005;63:3-23.

  7. Keiser J, Utzinger J. Trends in the core literature on tropical medicine: A bibliometric analysis from 1952-2002. Scientometrics. 2005;62:351-65.

  8. Lin CT, Chiang CT. Evaluating the performance of sponsored Chinese herbal medicine research. Scientometrics. 2007;70:67-84.

  9. Ramlogan R, Mina A, Tampubolon G, Metcalfe JS. Networks of knowledge: The distributed nature of medical innovation. Scientometrics. 2007;70:459-89.

  10. Riikonen P, Vihinen M. National research contributions: A case study on Finnish biomedical research. Scientometrics. 2008;77:207-22.

  11. Tsay MY, Chen YL. Journals of general & internal medicine and surgery: An analysis and comparison of citation. Scientometrics. 2005;64:17-30.

  12. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work. J Dermatol. 2011;38:419-31.

  13. Halder RM, Chappell JL. Vitiligo Update. Seminars in Cutaneous Medicine and Surgery. 2009;28:86-92.

  14. Lotti T, Berti S, Moretti S. Vitiligo therapy. Expert Opinion on Pharmacotherapy. 2009;10:2779-85.

  15. Naldi L, Sassi F. Vitiligo. New Engl J Med. 2009;360:1788.

  16. Paterson E. Vitiligo. Journal of Visual Communication in Medicine. 2010;33:166-8.

  17. Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clinic ExperimDermatol. 2010;35:736-9.

  18. Viles J, Monte D, Gawkrodger DJ. A patient's journey: Vitiligo. BMJ. 2010;341:938-9.

  19. Belinchon I, Ramos JM, Sánchez-Yus E, Betlloch I. Dermatological scientific production from European Union authors (1987-2000). Scientometrics. 2004;61:271-81.

  20. Firoozabadi MR, Firooz A, Gorouhi F, Dowlati Y. Iran's contribution to the dermatology literature [1]. Internat J Dermatol. 2007;46:659-60.

  21. Stegmann J, Grohmann G. Citation rates, knowledge export and international visibility of dermatology journals listed and not listed in the Journal Citation Reports. Scientometrics. 2001;50:483-502.

  22. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick's Dermatology in General Medicine. Vol. I. EE.UU.: Mac Graw Hill. 2007:616-21.

  23. de Moya-Anegón F, Chinchilla-Rodríguez Z, Vargas-Quesada B, Corera-Álvarez, E, Muñoz-Fernández FJ, González-Molina A, et al. Coverage analysis of Scopus: a journal metric approach. Scientometrics. 2007;73:53-78.

  24. Callon M, Courtial JP, Turner WA, Bauin S. From translations to problematic networks: an introduction to co-word analysis. SocSci Inform. 1983;22:191-235.

  25. Jacobs N. Co-term network analysis as a means of describing the information landscapes of knowledge communities across sectors. J Docum. 2002;58:548-62.

  26. Stegmann J, Grohmann G. Hypothesis generation guided by co-word clustering. Scientometrics. 2003;56:111-35.

  27. Whittaker J. Creativity and conformity in science: Titles, keywords and co-word analysis. Soc Stud Sci. 1989;19:473-96.

  28. Zhang J, Wolfram D, Wang PL, Hong Y, Gillis R. Visualization of health-subject analysis based on query term co-occurrences. J Am SocInfSci Technol. 2008;59:1933-47.

  29. Borgatti SP, Everett MG, Freeman LC. Ucinet for Windows: software for social network analysis. Harvard, MA, EE.UU.: Analytic Technologies. 2002.

  30. Breiger RL, Boorman SA, Arabie P. An algorithm for clustering relational data with applications to social network analysis and comparison with multidimensional scaling. J MathemPsychol. 1975;12:328-82.

  31. Ferrari HR, Catanesi I. Aplicación del algoritmo CONCOR para la interpretación de estereotipos de comportamiento. MastozoolNeotrop. 1998;5:117-21.

  32. Magnusson MG, Mascia D. Knowledge creation and appropriation in biotech R&D: The role of formal and informal organizational structures. Göteborg: Chalmers workshop "Innovations and Entrepreneurship in Biotech/Pharmaceuticals and IT/Telecom. 2003.

  33. Pearl MC, Schulman SR. Techniques for the analysis of social structure in animal societies. Advances in the Study of Behavior. 1983;13:107-46.

  34. Sallán-Leyes JM. Influencia del trabajo en equipo en el desarrollo y aplicación de conocimiento: el papel de las redes sociales, IX Congreso de Ingeniería de Organización. Gijón; 2005.

  35. Vargas-Quesada B. Visualización y Análisis de Dominios Científicos mediante redes pathfinder (PFNET). Granada: Universidad de Granada. Doctoral Dissertation. 2005.

  36. Vega-Almeida RL. Ciencia de la Información y paradigma social. Granada: Universidad de Granada. Doctoral Dissertation. 2010.

  37. Csigó P, Vedres B. The Discourse of Consolidation in Hungary: An Empirical Study of the Discursive Field in Economic Policy - a Network Analysis Approach. Spain: 5th European International Conference on Social Networks; 1998.

  38. Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. EE.UU.: Proceedings of the National Academy of Sciences of the United States of America. 2003;100:872-7.

  39. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clinic Oncol. 2005;23:2346-57.

  40. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, et al. Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccine. Canc Res. 2001;61:6451-8.

  41. Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Eng J Med. 2006;354:709-18.

  42. Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, et al. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:2982-7.

  43. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, De Jong LA, Vyth-Dreese FA, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Experim Med. 2003;198:569-80.

  44. Rosenberg SA, White DE. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy. J Immunother. 1996;19:81-4.

  45. Van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Experim Med. 1999;190:355-66.

  46. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo. J Experim Med. 2000;192:1637-43.

  47. Bor S, Feiwel M, Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Brit J Dermatol. 1969;81:83-8.

  48. Brostoff J. Autoantibodies in patients with vitiligo. Lancet. 1969;2(7613):177-8.

  49. Cunliffe WJ, Hall R, Newell DJ. Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Brit J Dermatol. 1968:80:135-9.

  50. Mackay IR. Autoimmune aspects of three skin diseases: pemphigus, cutaneous lupus erythematosus and vitiligo. Austr J Dermatol. 1967;9:113-21.

  51. Nordberg J, Arner ESJ. Reactive oxygen species, antioxidants and the mammalian thioredoxin system. Free Rad Biol Med. 2001;31:1287-312.

  52. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395-404.

  53. Le Poole IC, Van den Wijngaard RMJGJ, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol. 1996;148:1219-28.

  54. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigm Cell Res. 2002;15:87-92.

  55. Njoo MD, Westerhof W. Vitiligo: Pathogenesis and treatment. Am J ClinDermatol. 2001;2:167-81.

  56. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigm Cell Res. 2003;16:90-100.

  57. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Brit J Dermatol. 2001;145:476-9.

  58. Koga M. Vitiligo: A new classification and therapy. Brit J Dermatol. 1977;97:255-61.

  59. Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high intensity long wave ultraviolet light system. Arch Dermatol. 1976;112:1531-4.

  60. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology. 1998;197:167-70.

  61. Kovacs SO. Vitiligo. J Am AcadDermatol. 1998;38:647-66.

  62. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. ToxicolApplPharmacol. 2004;195:298-308.

  63. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo: Meta-analysis of the literature. Arch Dermatol. 1998;134:1532-40.

  64. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am AcadDermatol. 2000;42(2 I):245-53.

  65. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 1994;7:193-203.

  66. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am AcadDermatol. 2001;44:999-1003.

  67. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UV-A. Arch Dermatol. 1997;133(12):1525.

  68. Halder RM, Grimes PE, Cowan CA. Childhood vitiligo. J Am AcadDermatol. 1987;16:948-54.

  69. Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol. 1999: 26:653-7.

  70. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Álvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1 % tacrolimus vs 0.05 % clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-5.

  71. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: A case study on 33 patients. Dermatology. 1995;190:223-9.

  72. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. ClinImmunolImmunopathol. 1997;84:223-43.

  73. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. PigmCell Res. 2003;16:208-14.

  74. Schneider JW, Borlund P. Introduction to bibliometrics for construction and maintenance of thesauri: methodical considerations. Journal of Documentation. 2004;60(5):524-49.

  75. Hearst MA. The use of categories and clusters for organizing retrieval results. In: T. Strzalkowsky (Ed.): Natural language information retrieval. Netherlands: Springer, 1999:333-74.

  76. Han J, Kamber M. Datamining: Concepts an techniques. Burlington: Morgan Kaufmann Publishers, 2000.




2020     |     www.medigraphic.com